Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (31-40 of 193) with videos related to

Pageof 20
Sort By:
Life (Basel, Switzerland)|February 26, 2025
Advances in Multitarget Therapeutic Approaches for Immune-Mediated Glomerular DiseasesLuminita Voroneanu, Andreea Covic, Vladimir Tesar, et al.
Archives of Medical Research|December 11, 2007
Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritisMarketa Kazderova, Eva Jancova, Romana Rysava, et al.
Blood Purification|February 6, 2014
Methylation status of immune response genes promoters in cell-free DNA differs in hemodialyzed patients with diabetic nephropathy according to the intensity of anemia therapyMarie Korabecna, Eva Pazourkova, Ales Horinek, et al.
Journal of Nephrology|November 20, 2013
Cell-free nucleic acids as biomarkers in dialyzed patientsMarie Korabecna, Eva Pazourkova, Ales Horinek, et al.
Expert Opinion on Biological Therapy|April 18, 2012
Alterations in methylation status of immune response genes promoters in cell-free DNA during a hemodialysis procedureMarie Korabecna, Eva Pazourkova, Ales Horinek, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2012
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathyBarbora Svobodova, Eva Honsova, Pierre Ronco, et al.
Renal Failure|September 6, 2002
Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathyMiroslav Merta, Jana Reiterová, Vladimir Tesar, et al.
Frontiers in Immunology|November 24, 2022
Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternativesJan Miroslav Hartinger, Vojtech Kratky, Zdenka Hruskova, et al.
Pediatric Nephrology (Berlin, Germany)|June 10, 2024
Proliferative glomerulonephritis with monoclonal IgG deposits in an adolescent successfully treated with daratumumabEva Svabova, Jakub Zieg, Martina Sukova, et al.
BMC Nephrology|November 6, 2013
Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional studyOskar Zakiyanov, Vitezslav Kriha, Jan Vachek, et al.
Pageof 20

Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Life (Basel, Switzerland)|February 26, 2025
Advances in Multitarget Therapeutic Approaches for Immune-Mediated Glomerular DiseasesLuminita Voroneanu, Andreea Covic, Vladimir Tesar, et al.
Archives of Medical Research|December 11, 2007
Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritisMarketa Kazderova, Eva Jancova, Romana Rysava, et al.
Blood Purification|February 6, 2014
Methylation status of immune response genes promoters in cell-free DNA differs in hemodialyzed patients with diabetic nephropathy according to the intensity of anemia therapyMarie Korabecna, Eva Pazourkova, Ales Horinek, et al.
Journal of Nephrology|November 20, 2013
Cell-free nucleic acids as biomarkers in dialyzed patientsMarie Korabecna, Eva Pazourkova, Ales Horinek, et al.
Expert Opinion on Biological Therapy|April 18, 2012
Alterations in methylation status of immune response genes promoters in cell-free DNA during a hemodialysis procedureMarie Korabecna, Eva Pazourkova, Ales Horinek, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2012
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathyBarbora Svobodova, Eva Honsova, Pierre Ronco, et al.
Renal Failure|September 6, 2002
Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathyMiroslav Merta, Jana Reiterová, Vladimir Tesar, et al.
Frontiers in Immunology|November 24, 2022
Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternativesJan Miroslav Hartinger, Vojtech Kratky, Zdenka Hruskova, et al.
Pediatric Nephrology (Berlin, Germany)|June 10, 2024
Proliferative glomerulonephritis with monoclonal IgG deposits in an adolescent successfully treated with daratumumabEva Svabova, Jakub Zieg, Martina Sukova, et al.
BMC Nephrology|November 6, 2013
Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional studyOskar Zakiyanov, Vitezslav Kriha, Jan Vachek, et al.
Pageof 20